SPRINGFIELD – To expand access to birth control – especially for women with limited financial resources – State Senator Melinda Bush (D-Grayslake) is championing a measure to allow people to receive contraceptives without visiting a doctor.
“Birth control is a basic health care service and should be treated as such,” Bush said. “Providing greater access to contraceptives is providing a more equitable health care system.”
Many women struggle to access hormonal contraceptives, which historically have only been prescribed through a physician. They may not know where to go, or are unable to afford doctor’s appointments. Pharmacists, however, are typically much more accessible than a physician.
To give women easier, more affordable access to birth control, Bush is pushing a measure to allow pharmacists to issue hormonal contraceptives, including oral tablets, vaginal rings and topical patches.
Under the proposed legislation, pharmacists who wish to participate would have to meet several educational requirements to provide them with the best tools to help patients complete a self-screening risk assessment. Once the assessment is finished, the pharmacist would provide counseling and education on all methods of contraception, then help the patient choose a form of birth control.
Currently, 16 states and Washington, D.C. allow pharmacists to prescribe and dispense self-administered hormonal birth control.
“It’s simple: Birth control saves lives and prevents unplanned pregnancy,” Bush said. “Family planning and reproductive health care is a personal choice that should not be limited by economic or social status.”
Bush has been a steadfast advocate for women’s reproductive rights since first joining the General Assembly. She has spearheaded a number of measures to protect women’s health, including the monumental 2019 Reproductive Health Act, which repealed outdated abortion laws that have been blocked by the courts and ensured that reproductive health care is treated like all other health care and not as a crime.
House Bill 135 passed the Senate Insurance Committee Wednesday and now heads to the full Senate for further consideration.